[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20032582L - 1,2,4-oksadiazolderivater som HPPAR alfa agonister - Google Patents

1,2,4-oksadiazolderivater som HPPAR alfa agonister

Info

Publication number
NO20032582L
NO20032582L NO20032582A NO20032582A NO20032582L NO 20032582 L NO20032582 L NO 20032582L NO 20032582 A NO20032582 A NO 20032582A NO 20032582 A NO20032582 A NO 20032582A NO 20032582 L NO20032582 L NO 20032582L
Authority
NO
Norway
Prior art keywords
oxadiazole derivatives
alpha agonists
hppar alpha
hppar
agonists
Prior art date
Application number
NO20032582A
Other languages
English (en)
Other versions
NO20032582D0 (no
Inventor
Kevin Guangcheng Liu
Francoise Jeanne Gellibert
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20032582D0 publication Critical patent/NO20032582D0/no
Publication of NO20032582L publication Critical patent/NO20032582L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO20032582A 2000-12-08 2003-06-06 1,2,4-oksadiazolderivater som HPPAR alfa agonister NO20032582L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0029974.3A GB0029974D0 (en) 2000-12-08 2000-12-08 Chemical compounds
PCT/GB2001/005400 WO2002046174A1 (en) 2000-12-08 2001-12-06 1, 2, 4-oxadiazole derivatives as hppar alpha agonists

Publications (2)

Publication Number Publication Date
NO20032582D0 NO20032582D0 (no) 2003-06-06
NO20032582L true NO20032582L (no) 2003-08-07

Family

ID=9904715

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032582A NO20032582L (no) 2000-12-08 2003-06-06 1,2,4-oksadiazolderivater som HPPAR alfa agonister

Country Status (13)

Country Link
US (1) US7141591B2 (no)
EP (1) EP1355890A1 (no)
AU (2) AU2090202A (no)
CA (1) CA2430847A1 (no)
CZ (1) CZ20031581A3 (no)
GB (1) GB0029974D0 (no)
IL (2) IL156174A0 (no)
MX (1) MXPA03005008A (no)
NO (1) NO20032582L (no)
NZ (1) NZ526251A (no)
PL (1) PL360974A1 (no)
WO (1) WO2002046174A1 (no)
ZA (1) ZA200304312B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002347985A1 (en) 2001-11-15 2003-06-10 Eli Lilly And Company Peroxisome proliferator activated receptor alpha agonists
GB0214139D0 (en) * 2002-06-19 2002-07-31 Glaxo Group Ltd Chemical compounds
CA2490972C (en) * 2002-07-09 2012-05-29 Bristol-Myers Squibb Company Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
US7507832B2 (en) 2003-12-22 2009-03-24 Eli Lilly And Company Triazole PPAR modulators
PT2628733E (pt) * 2010-10-14 2015-03-24 Daiichi Sankyo Co Ltd Derivado de acilbenzeno
TWI529169B (zh) 2011-07-29 2016-04-11 第一三共股份有限公司 N-雜環取代醯胺衍生物
AU2013210394A1 (en) * 2012-01-18 2014-08-14 Daiichi Sankyo Company,Limited Substituted phenylazole derivative

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998032734A1 (en) * 1997-01-22 1998-07-30 Rhone-Poulenc Rorer Pharmaceuticals Inc. SUBSTITUTED β-THIOCARBOXYLIC ACIDS
BR0010126A (pt) 1999-04-28 2002-02-26 Aventis Pharma Gmbh Derivados de ácido tri-arìlico como ligandos receptores de ppar
DE60005973T2 (de) * 1999-08-27 2004-05-13 Eli Lilly And Co., Indianapolis Biaryl-oxa(thia)zolderivate und ihre verwendung als ppars modulatoren
US6875780B2 (en) * 2002-04-05 2005-04-05 Warner-Lambert Company Compounds that modulate PPAR activity and methods for their preparation

Also Published As

Publication number Publication date
AU2002220902B2 (en) 2005-06-02
EP1355890A1 (en) 2003-10-29
US7141591B2 (en) 2006-11-28
AU2090202A (en) 2002-06-18
MXPA03005008A (es) 2003-09-05
CZ20031581A3 (cs) 2003-08-13
NO20032582D0 (no) 2003-06-06
ZA200304312B (en) 2004-10-13
GB0029974D0 (en) 2001-01-24
IL156174A0 (en) 2003-12-23
CA2430847A1 (en) 2002-06-13
US20040132787A1 (en) 2004-07-08
NZ526251A (en) 2006-03-31
IL156174A (en) 2008-11-03
PL360974A1 (en) 2004-09-20
WO2002046174A1 (en) 2002-06-13

Similar Documents

Publication Publication Date Title
NO20030929D0 (no) Guanidinobenzamider som MC4-R agonister
NO20041560L (no) 1,6-nafthyridinderivater som antidiabetiske midler
DK1379522T3 (da) Dihydro-benzo(b)(1,4)diazeping-2-on-derivater som MGLUR2-antagonister I
NO20044654L (no) Piperidinoylpiperidiner som 5-HTIF-agonister
DK1244642T3 (da) Substituerede oxazol- og thiazolderivater som HPPAR-alfa-aktivatorer
CY2014041I2 (el) 2,3-διυδρο-6-νιτροϊμιδαζο 2,1 -b-οξαζολια
DK1446394T3 (da) Hidtil ukendte 1,2,4-thiadiazolderivater som melanocortinreceptormodulatorer
DK1442030T3 (da) Thiopen- og thiazolsulfonamider som antineoplastiske midler
DK1339685T3 (da) Biphenylcarboxamider, der er egnede som lipidsænkende midler
BR0300119B1 (pt) composiÇço aquosa.
NO20015668D0 (no) Substituerte imidazotiazoler som antidepressive midler
DE50107988D1 (de) Substituierte 1,2,3,4-tetrahydrochinolin-2-carbonsäurederivate
NO20041455L (no) Zirkonium-/metalloksidfibrer.
NO20033700L (no) Isoksazolinderivater som anti-depressive midler
NO20032582L (no) 1,2,4-oksadiazolderivater som HPPAR alfa agonister
DK1231211T3 (da) Thiazolidindion-derivater som antidiabetika
DK1532141T3 (da) 2-pyrrolidin-2-yl-[1,3,4]-oxadiazol-derivater og anvendelse deraf som antidepressiv
DK1240163T3 (da) 3-(4,5-Dihydroisoxazol-5-yl)-benzoylpyrazoler
DE60315471D1 (de) 2,5-disubstituierte 3-mercaptopentansaure
NO20044413L (no) 1,2-Dihydropyrazol-3-oner som cytokinmediatorer
NO20044405L (no) Neurotensinaktive 2,3-diaryl-pyrazolidin derivater
NO20031239D0 (no) 1-amino-alkylsykloheksaner som trypanocidale midler
NO20053110D0 (no) 2-oksyamino-1-cyklopenten-1-nitriler som materialbeskyttelsesmidler.
RU2000116332A (ru) Антгельминтное средство
DK1318800T3 (da) 1-amino-alkylcyclohexaner som trypanocide midler

Legal Events

Date Code Title Description
RE Reestablishment of rights (par. 72 patents act)
FC2A Withdrawal, rejection or dismissal of laid open patent application